0001410442-17-000008.txt : 20170711 0001410442-17-000008.hdr.sgml : 20170711 20170711200344 ACCESSION NUMBER: 0001410442-17-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170707 FILED AS OF DATE: 20170711 DATE AS OF CHANGE: 20170711 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jain Vivek CENTRAL INDEX KEY: 0001410442 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 17960794 MAIL ADDRESS: STREET 1: ICU MEDICAL, INC. STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2017-07-07 0 0000883984 ICU MEDICAL INC/DE ICUI 0001410442 Jain Vivek 951 CALLE AMANECER SAN CLEMENTE CA 92673 1 1 0 0 Chairman and CEO Common Stock 2017-07-07 4 X 0 69014 58.79 A 110925 D Common Stock 2017-07-07 4 S 0 40046 170.5273 D 70879 D Common Stock 2017-07-07 4 S 0 19114 171.2198 D 51765 D Common Stock 2017-07-07 4 S 0 9854 173.2203 D 41911 D Common Stock 2017-07-10 4 X 0 3704 58.79 A 45615 D Common Stock 2017-07-10 4 S 0 3704 171.0 D 41911 D Common Stock 2017-07-11 4 X 0 27282 58.79 A 69193 D Common Stock 2017-07-11 4 S 0 27282 170.0 D 41911 D Non-Qualified Stock Option (right to buy) 58.79 2017-07-07 4 X 0 69014 58.79 D 2024-02-24 Common Stock 69014 613352 D Non-Qualified Stock Option (right to buy) 58.79 2017-07-10 4 X 0 3704 58.79 D 2024-02-24 Common Stock 3704 609648 D Non-Qualified Stock Option (right to buy) 58.79 2017-07-11 4 X 0 27282 58.79 D 2024-02-24 Common Stock 27282 582366 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.00 to $170.95, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.00 to $171.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.50 to $173.35, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. All shares sold were sold at the exact price disclosed. Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Transaction is the exercise of a derivative security; see Column 2. By: Paula Darbyshire, Attorney-in-fact For: Vivek Jain 2017-07-11